A Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer
Open Access
- 11 June 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6421
Abstract
Photodynamic Therapy (PDT) is recognized for its exceptional effectiveness as a promising cancer treatment method. However, it is noted that overexposure to the dosage and sunlight in traditional PDT can result in damage to healthy tissues, due to the low tumor selectivity of currently available photosensitizers (PSs). To address this challenge, we introduce herein a new strategy where the small molecule-targeted agent, erlotinib, is integrated into a boron dipyrromethene (BODIPY)-based PS to form conjugate 6 to enhance the precision of PDT. This conjugate demonstrates optical absorption, fluorescence emission, and singlet oxygen generation efficiency comparable to the reference compound 7, which lacks erlotinib. In vitro studies reveal that, after internalization, conjugate 6 predominantly accumulates in the lysosomes of HepG2 cells, exhibiting significant photocytotoxicity with an IC50 value of 3.01 µM. A distinct preference for HepG2 cells over HELF cells is observed with conjugate 6 but not with compound 7. In vivo experiments further confirm that conjugate 6 has a specific affinity for tumor tissues, and the combination treatment of conjugate 6 with laser illumination can effectively eradicate H22 tumors in mice with outstanding biosafety. This study presents a novel and potential PS for achieving precise PDT against cancer.Keywords
Funding Information
- Natural Science Foundation of China (82374081, 21471033, 2020J01440)
- Natural Science Foundation of Fujian Province, China (82374081, 21471033, 2020J01440)
This publication has 50 references indexed in Scilit:
- Lysosome-targeted Aza-BODIPY photosensitizers for anti-cancer photodynamic therapyBioorganic & Medicinal Chemistry, 2023
- Hypoxia‐Responsive Photosensitizer Targeting Dual Organelles for Photodynamic Therapy of TumorsSmall, 2022
- Hierarchical nano-to-molecular disassembly of boron dipyrromethene nanoparticles for enhanced tumor penetration and activatable photodynamic therapyBiomaterials, 2021
- A Bifunctional Zwitterion‐Modified Porphyrin for Photodynamic Nondestructive Tooth Whitening and Biofilm EradicationAdvanced Functional Materials, 2021
- Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic TherapyAdvanced Science, 2021
- Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic TherapyChempluschem, 2020
- Enzyme‐Triggered Disassembly of Perylene Monoimide‐based Nanoclusters for Activatable and Deep Photodynamic TherapyAngewandte Chemie International Edition, 2020
- Advances in nanomaterials for photodynamic therapy applications: Status and challengesBiomaterials, 2020
- Phthalocyanines as medicinal photosensitizers: Developments in the last five yearsCoordination Chemistry Reviews, 2019
- A Multifunctional Nanomicelle for Real‐Time Targeted Imaging and Precise Near‐Infrared Cancer TherapyAngewandte Chemie International Edition, 2014